Search clinical trials for: insulin-like growth factor I

Total 4532 results

Children's Hospital of Philadelphia

Completed

Dose Ranging Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism

Hyperinsulinism
Beth Israel Deaconess Medical Center

Completed

Study of Recombinant Human Insulin-Like Growth Factor I in Patients With Severe Insulin Resistance

Hyperglycemia | Insulin Resistance

United States
Wright State University

Recruiting

Gene Expression Changes In Young and Geriatric Skin

Aging | UVB Phototherapy Burn | Insulin-like Growth Factor 1

United States
Children's Hospital of Philadelphia

Completed

Phase II Long Term, Randomized Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism

Hyperinsulinism
Bispebjerg Hospital
The Danish Medical Research Council

Unknown

Patellar Tendinopathy - Effect of Training and Enhancement of the Collagen Synthesis by Insulin-like Growth Factor-I (IGF-I)

Tendinopathy

Denmark
FDA Office of Orphan Products Development
Children's Hospital of Philadelphia

Completed

Short Term Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism

Hyperinsulinism
Astellas Pharma Inc

Completed

Dose-finding Study of ASP2151 in Subjects With Herpes Zoster

Herpes Zoster

Japan
Children's Hospital of Fudan University

Completed

Nutrition and Growth in Very Preterm Infants

Growth | Premature

China
Massachusetts General Hospital

Completed

Effects of rhIGF-1 on Bone Metabolism in Adolescent Girls With Anorexia Nervosa (814)

Disorder of Bone Density and Structure, Unspecified

United States
Mayo Clinic
National Institute of Neurological Disorders and Stroke (NINDS); ALS Association and other collaborators

Completed

Insulin-like Growth Factor-1 in Amyotrophic Lateral Sclerosis (ALS) Trial

Amyotrophic Lateral Sclerosis

United States, Puerto Rico
Yale University

Completed

Reducing the Risk of Metabolic Decompensation in Diabetic Adolescents by Supervised School Administration of Insulin

Type 1 Diabetes Mellitus

United States
Cairo University

Not yet recruiting

Growth Hormone in EB

Epidermolysis Bullosa Dystrophica
Icahn School of Medicine at Mount Sinai
National Institute of Mental Health (NIMH)

Completed

Clinical Trial in 22q13 Deletion Syndrome(Phelan-McDermid Syndrome)

Phelan-McDermid Syndrome | 22q13 Deletion Syndrome

United States
Novo Nordisk A/S

Completed

Efficacy and Safety of Three Times a Day BIAsp-70 Compared to Two Times a Day BIAsp-30 in Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Japan
Montreal Heart Institute

Not yet recruiting

Inhaled Milrinone and Epoprostenol for the Prevention of Difficult Cardiac Pulmonary Bypass Separation (MILAN)

Right Ventricular Dysfunction | Right Heart Failure
AstraZeneca

Completed

Clinical Outcomes of Exenatide Versus Basal Insulin

Type 2 Diabetes

United Kingdom
Assiut University

Not yet recruiting

Assessment of the Diagnostic Role of Serum Insulin-like Growth Factor Binding Protein-3 as a Potential Biomarker for Colorectal Cancer (CRC) in Egypt

Colorectal Cancer
Novo Nordisk A/S

Completed

A Multiple Dose Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0123-0000-0338 in Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Germany
Novo Nordisk A/S

Recruiting

A Research Study to Look Into How Semaglutide, Together With a Lower Dose of Insulin Glargine, Compares to a Higher Dose of Insulin Glargine Alone in People With Type 2 Diabetes (SUSTAIN OPTIMIZE)

Obesity | Diabetes Mellitus, Type 2

United States, Spain, Portugal, Italy, Greece, Romania, Slovakia, Czechia, South Africa, Ukraine
Novo Nordisk A/S

Completed

Trial to Compare NNC0123-0000-0338 in a Tablet Formulation and Insulin Glargine in Subjects With Type 2 Diabetes Currently Treated With Oral Antidiabetic Therapy

Diabetes Mellitus, Type 2 | Diabetes

Germany
Novo Nordisk A/S

Completed

A Study to Compare Insulin Intensification of Biphasic Insulin Aspart 30 and Insulin Analogues (Insulin Glargine and Insulin Aspart) in Insulin naïve Type 2 Diabetic Patients

Diabetes Mellitus, Type 2 | Diabetes

India, Serbia, Bulgaria, Australia, Korea, Republic of, Thailand, Turkey, United Arab Emirates, Hungary
Novo Nordisk A/S

Completed

Comparison of NN5401 Versus Biphasic Insulin Aspart 30 on a Twice Daily Regimen in Subjects With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2 | Diabetes

Japan
Novo Nordisk A/S

Completed

Comparison of Biphasic Insulin Aspart 30 Versus Insulin Glargine Both in Combination With Metformin and Glimepiride in Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Poland, Spain, Sweden, Malaysia, France, Netherlands, India, Argentina, South Africa, Romania, Former Serbia and Montenegro, Austria, Czech Republic, Philippines, Mexico
Novo Nordisk A/S

Completed

Effect of Food on the Pharmacokinetics of NNC0123-0000-0338 in a Tablet Formulation in Healthy Subjects

Healthy | Diabetes

Germany
National Cancer Institute (NCI)

Terminated

Insulin-like Growth Factor 1 Receptor (IGF-1R) Antibody AMG479 (Ganitumab) in Combination With the Src Family Kinase (SFK) Inhibitor Dasatinib in People With Embryonal and Alveolar Rhabdomyosarcoma

Rhabdomyosarcoma | Rhabdomyosarcoma, Alveolar | Rhabdomyosarcoma, Embryonal

United States
Novo Nordisk A/S

Completed

A Trial Investigating the Pharmacokinetics and Pharmacodynamics of NNC0123-0000-0338 in a Tablet Formulation With Three Different Coatings in Healthy Subjects

Healthy | Diabetes

Germany
Boston Children's Hospital
International Rett Syndrome Foundation

Completed

Treatment of Rett Syndrome With Recombinant Human IGF-1

Rett Syndrome

United States
Novo Nordisk A/S

Completed

Observational Study on Safety and Efficacy of Biphasic Insulin Aspart in Type 2 Diabetes Patients

Diabetes Mellitus, Type 2 | Diabetes

Israel
david andrews

Completed

Antisense102: Pilot Immunotherapy for Newly Diagnosed Malignant Glioma

Neoplasms | Malignant Glioma

United States
University of Pittsburgh

Completed

Insulin Start Therapy Application With Resources and Training (I-START)

Diabetes Mellitus, Type 2

United States
Novo Nordisk A/S

Completed

Comparison of the Blood Sugar Lowering Effect of Biphasic Insulin Aspart 30 and Insulin Glargine Both Combined With Metformin and Glimepiride in Chinese and Japanese Subjects With Type 2 Diabetes New to Insulin Treatment (EasyMix)

Diabetes Mellitus, Type 2 | Diabetes

Japan, China
Kazakhstan's Medical University "KSPH"
Vyacheslav Notanovich Lokshin; Nurgalieva Zhanar Zhenisovna; Manzhuova Lyazzat... and other collaborators

Completed

Health Status of Children Born After Assisted Reproductive Technologies

Child Development | Health Status | Children Born After Assisted Reproductive Technologies

Kazakhstan
Sygehus Lillebaelt
CeraPedics, Inc

Unknown

The Clinical Effect of i-FACTOR® Versus Allograft in Non-instrumented Posterolateral Spondylodesis Operation in the Elderly With Spinal Stenosis Due to Degenerative Spondylolisthesis (IVANOS)

Spinal Stenosis

Denmark
Novo Nordisk A/S

Not yet recruiting

Remote Study Collecting Blood Glucose Values and Activity Data in Patients With Type 2 Diabetes on Different Treatments

Diabetes Mellitus, Type 2
Istituto Ortopedico Rizzoli

Recruiting

Study of Parameters of Osteosarcopenia in Patients With Hip Fracture

Osteoarthritis, Hip | Osteoporotic Fracture of Femur

Italy
The University of Texas Medical Branch, Galveston
National Institute of General Medical Sciences (NIGMS)

Completed

Assessment of Mechanisms of Improved Wound Healing

Burns

United States
Emory University
National Institute of Mental Health (NIMH)

Completed

Promoting Transactional Supports to Optimize Social Communication Outcomes for Infants and Their Families

Autism Spectrum Disorder

United States
Novo Nordisk A/S

Completed

Efficacy and Safety of Biphasic Insulin Aspart 30 in Combination With Metformin in Type 2 Diabetes (EUROMIX)

Diabetes Mellitus, Type 2 | Diabetes

Austria, Hungary, Slovenia, Germany, Czech Republic, Poland, Slovakia
Rutgers, The State University of New Jersey
Alzheimer's Association

Recruiting

COMMETS- Combination MCI Metabolic Syndrome

Metabolic Syndrome | Alzheimer Disease | Mild Cognitive Impairment

Israel
Vastra Gotaland Region

Completed

Digital Treatment for Migraines - a Feasibility Study

Migraine Without Aura | Migraine With Aura

Sweden
Centre Hospitalier Universitaire Dijon

Active, not recruiting

Effect of Weekly GLP1 Agonist Treatment in "Double Diabetes" (TOLEDDO)

Double Diabetes

France
State University of Maringá
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.; Financiadora... and other collaborators

Completed

Insulin Complexation With Hydroxypropyl-beta-cyclodextrin: Use of the Complex in Gel for Healing of Pressure Ulcers

Wound | Pressure Ulcer
Federal State Budgetary Institution, V. A. Almazov...

Unknown

Genetic and Epigenetic Mechanisms of Developing Gestational Diabetes Mellitus and Its Effects on the Fetus

Gestational Diabetes Mellitus

Russian Federation
Spine Centre of Southern Denmark
CeraPedics, Inc; Ortotech

Completed

The Clinical Effect of i-FACTOR® Versus Allograft in Non-instrumented Posterolateral Fusion The IVANOS-study (IVANOS)

Low Back Pain | Spinal Stenosis

Denmark
Cambridge University Hospitals NHS Foundation Trust

Terminated

Keratinocyte Growth Factor to Prevent Autoimmunity After Alemtuzumab Treatment of Multiple Sclerosis (CAM-THY)

Multiple Sclerosis

United Kingdom
Minia University

Active, not recruiting

Comparison of Two Different Types of Platelet Concentrate to Augment Bone Around Immediate Dental Implant

Dental Implant Failure Nos

Egypt
Novo Nordisk A/S

Completed

Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Children and Adolescents With Type 1 Diabetes (onset®7)

Diabetes | Diabetes Mellitus, Type 1

Germany, United States, India, Israel, Italy, Russian Federation, Japan, Finland, Serbia, Turkey, Bulgaria, Estonia, Czechia, Lithuania, Ukraine, Poland, Latvia, Puerto Rico
Novo Nordisk A/S

Completed

Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes (onset® 2)

Diabetes Mellitus, Type 2 | Diabetes

United States, Croatia, India, Israel, Russian Federation, Slovakia, Canada, Serbia, United Kingdom, Puerto Rico
Novo Nordisk A/S

Completed

Efficacy and Safety of FIAsp Compared to Insulin Aspart Both in Combination With Insulin Detemir in Adults With Type 1 Diabetes (onset® 1)

Diabetes | Diabetes Mellitus, Type 1

United States, Poland, Finland, Belgium, Hungary, United Kingdom, Germany, Canada, Czechia
Pfizer

Completed

Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Renal Cell Carcinoma

Kidney Neoplasms

United States, Germany, France

Search clinical trials for: insulin-like growth factor I

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Turkmenistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations